A8362112
Vernakalant , ≥98% , 794466-70-9
| Pack Size | Price | Stock | Quantity |
| 10MG | RMB1359.20 | In Stock |
|
| 50MG | RMB4799.20 | In Stock |
|
| 500MG | RMB10708.00 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Boiling point: | 479.0±45.0 °C(Predicted) |
| Density | 1.14±0.1 g/cm3(Predicted) |
| storage temp. | Store at -20°C |
| solubility | DMSO |
| form | Powder |
| pka | 14.79±0.20(Predicted) |
Description and Uses
Vernakalant is a potassium channel blocker that was approved in Europe in 2010 for treatment of atrial fibrillation (AF), a condition of cardiac arrhythmia in which the atria of the heart beat irregularly due to changes in cardiac ion channel function and distribution. Vernakalant has activity for cardiac Na+ and K+ channels and also for the atrial-selective Kv1.5 channel. Vernakalant (RSD1235) was characterized in animal models to assess efficacy, atrial selectivity, and reduction in side effects.
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H335 |
| Precautionary statements | P261-P280-P301+P312-P302+P352-P305+P351+P338 |
